Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice

This publication has 19 references indexed in Scilit:

• Controlled-release coevaporates of dipyridamole prepared with acrylic polymers
  International Journal of Pharmaceutics, 1994
• Distribution, kinetics and elimination of radioactivity after intravenous and intramuscular injection of 14C-savoxepine loaded poly(D,L-lactic acid) nanospheres to rats
  Journal of Controlled Release, 1994
• CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity
  Antimicrobial Agents and Chemotherapy, 1993
• HIV‐1 Protease Inhibitors: Development, Status, and Potential Role in the Treatment of AIDS
  Archiv der Pharmazie, 1993
• Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size
  International Journal of Pharmaceutics, 1992
• Intracellular targeting of antibiotics by means of biodegradable nanoparticles
  Journal of Controlled Release, 1992
• Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease
  Antimicrobial Agents and Chemotherapy, 1991
• Jejunal Absorption, Pharmacological Activity, and Pharmacokinetic Evaluation of Indomethacin-Loaded Poly(d,l-Lactide) and Poly(Isobutyl-Cyanoacrylate) Nanocapsules in Rats
  Pharmaceutical Research, 1991
• Nanocapsules as carriers for oral peptide delivery
  Journal of Controlled Release, 1990
• HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -Protease
  Science, 1986